- Lobbying
- Lobbying by Roche Diagnostics Corporation, Inc.
Lobbying Relationship
Bills mentioned
H.R.748: CARES Act
Sponsor: Joe Courtney (D-Conn.)
H.R.133: Consolidated Appropriations Act, 2021
Sponsor: Henry Cuellar (D-Texas)
H.R.747: Access to TESTs Act
Sponsor: Diana DeGette (D-Colo.)
S.1018: Access to TESTs Act
Sponsor: Amy Klobuchar (D-Minn.)
H.R.6000: Cures 2.0 Act
Sponsor: Diana DeGette (D-Colo.)
H.R.4128: VALID Act of 2021
Sponsor: Diana DeGette (D-Colo.)
S.2209: VALID Act of 2021
Sponsor: Richard M. Burr (R-N.C.)
S.3799: PREVENT Pandemics Act
Sponsor: Patty Murray (D-Wash.)
H.R.2617: Consolidated Appropriations Act, 2023
Sponsor: Gerald E. Connolly (D-Va.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Rachel Stauffer | 2013-2015: Health Policy Director, Rep. Diana DeGette; 2008-2011: Legislative Assistant, Senior Legislative Assistant, Rep. John Tierney |
James P. Moran | Member of Congress, 1991-2015 |
Eric Zimmerman | n/a |
Paul Radensky MD | n/a |
Jennifer Ohn | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate